Navigation Links
Iprona AG: Human Trial Results Published in "Nutrients" / Unique Elderberry Formula Protects Air Travelers from Colds
Date:4/7/2016

The final results of a large human trial, which investigated the benefits of a proprietary elderberry formula on respiratory health for air travelers, have been published in the journal Nutrients. The two-year randomized, double-blind, placebo-controlled clinical trial had promising results.

According to the U.S. Centers for Disease Control and Prevention (CDC), up to 20% of all travelers experience respiratory infections that require them to seek medical care. For those traveling long distance, upper respiratory infections are among the most prevalent problems they’ll face — along with jet lag and fatigue. The new study showed that taking an elderberry formula could help.

The trial involved 312 economy class passengers on intercontinental flights from Australia. It was conducted at the School of Pharmacy, Griffith University, Australia. Subjects were divided up into two groups. One group took 600–900mg per day of Iprona AG´s membrane-enriched elderberry formula before, during and after travel. The other group received a placebo.

The group that took the elderberry formula experienced significant health benefits compared to the placebo group. If participants in either group contracted a cold, those who took the elderberry formula experienced a significantly shorter illness duration, with less severe symptoms. They also experienced better physical health after their travels.

As the research showed, "Travelers using elderberry … on average experienced a 2-day shorter duration of [their] cold and also noticed a reduction in cold symptoms. Physical health may stabilize during air travel due to elderberry.”

The same elderberry formula used in this trial was previously the subject of a clinical study by Dr. Christian Kravitz at the University of Giessen. In that study, the formula was found to have clear inhibitory effects against influenza A and B viruses, as well as against four bacteria known to cause upper respiratory infections.

Together, these studies pave the way for formulations targeted to support the health of travelers, whether making a journey by air or other means.

The extract used in the research was a unique formulation produced by the Italian company, Iprona AG, using their proprietary membrane ultrafiltration enrichment process. The elderberry extract is standardized to optimize its concentration of anthocyanins and active compounds in the original fruit matrix.

“The high potency of the extract used in these studies is the result of a very unique European elderberry variety, the Haschberg variety, and a proprietary extraction method,” said Iprona AG Technical Director Anthony Jacobs.

Iprona AG markets these premium health ingredients under their BerryPharma® brand.

For samples or more info on the membrane enriched elderberry formula contact:

Britta Busch
IPRONA AG/SPA
Business Unit BerryPharma® Extracts
T: +49 2174 307 62 13 - britta(dot)busch(at)berrypharma(dot)com

Read the full story at http://www.prweb.com/releases/2016/04/prweb13318181.htm.


'/>"/>
Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved


Related medicine news :

1. Peptide derived from cows milk kills human stomach cancer cells in culture
2. Trivedi Masters Invite People across the Globe for the Historic Event, 'TRANSFORMING HUMANITY'
3. Human Circuit Completes Town of Vienna’s Council Chambers and Live Cable TV Broadcasting Project
4. ENT and Allergy Associates, LLP® Adds Resources to Its Human Resources Department, Welcomes Eric M. Saidel, JD as Its New HR Director
5. Animal, human health benefits anticipated from universitys premier biomedical instrument
6. Western University of Health Sciences’ Gala Fundraiser Emphasizes Humanism and Caring
7. Tel Aviv University part of team launching global Human Brain Project
8. Geranylgeraniol suppresses the viability of human prostate cancer cells and HMG CoA reductase
9. NHS Human Services Foundation to Host 10th Annual Leading the Way Awards Gala
10. Mahendra Trivedi Announces the New Master During the Historical Event “Transforming Humanity”
11. China Human Vaccine Industry Report, 2012-2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... July 21, 2017 , ... ... to renovate and improve the Ramsey County Medical Examiners Facility located in Saint ... the $2.5 million project is scheduled to start in late 2017/early 2018. ...
(Date:7/21/2017)... ... ... Bernard R. Bach, Jr., MD, orthopaedic surgeon at Rush University Medical Center ... Medicine (AOSSM) , received the 2017 Robert E. Leach Sports Medicine Leadership award on ... award is given annually to honor those who have made a significant contribution to ...
(Date:7/21/2017)... ... 21, 2017 , ... MedMatchPlus+ has launched a residency application ... a residency in a United States hospital. Being accepted into a residency is ... to data released by the ECFMG®, every year, 50 percent of international medical ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the first ... the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related functions ... activity levels decline over time. The study, presented today at the American ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a leading provider of value-based ... Medical Center as Richmond Chief Medical Officer. Dr. McCarter, formerly Associate Professor ... Medical Officer of Ambulatory Services for the UVA Health System, brings 30 years of ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... CARLSBAD, Calif. , July 10, 2017  The ... in Boston, MA at the ... unequaled value and unparalleled access to global decision makers ... to draw 800+ life science leaders during two impactful ... Boston, and provides delegates with additional networking opportunities with ...
(Date:7/6/2017)... , July 6, 2017 ThriveRx, the nutrition division of ... their families to thrive on nutrition support. To celebrate its ... new site has a fresh new look with improved organization to create ... ... ...
(Date:7/5/2017)... JERUSALEM , July 5, 2017 ... www.oramed.com ), a clinical-stage pharmaceutical company ... today that it has received approval from the Israel Securities ... Stock Exchange (TASE). Oramed common stock will commence trading on ... Based on the current market capitalization of the Company, it ...
Breaking Medicine Technology: